CorMedix Inc.
CRMD
$6.38
$0.010.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,009.40% | 452.12% | 196.32% | 134.20% | 61.31% |
| Total Depreciation and Amortization | 4,593.23% | 2,081.31% | 296.52% | 494.58% | 337.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -259.40% | -865.76% | 46.49% | 27.67% | 13.96% |
| Change in Net Operating Assets | 118.44% | -170.73% | -676.04% | -3,681.31% | -1,866.90% |
| Cash from Operations | 445.84% | 234.49% | 159.98% | 70.07% | -31.78% |
| Capital Expenditure | -1,848.28% | -36.88% | 86.57% | 82.64% | 64.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.03% | -106.56% | -191.73% | 75.06% | 227.56% |
| Cash from Investing | -1,552.73% | -1,509.82% | -194.51% | 84.04% | 224.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 262.84% | 556.16% | 160.34% | -31.06% | -52.58% |
| Repurchase of Common Stock | -585.52% | -654.02% | -457.86% | -310.12% | -46.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 806.01% | 1,520.17% | 158.75% | -33.14% | -52.93% |
| Foreign Exchange rate Adjustments | 100.00% | -110.53% | 83.33% | -233.33% | -171.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,525.90% | 177.80% | 1,393.46% | 214.62% | -783.97% |